See also this year's filing and all EDGAR filings for this company.
PDF Report 0001316175_2014_Anthera_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001316175, Anthera Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 26,304,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 812,000 |
| 3 | remainder_Assets | 10,301,000 |
| 4 | LiabilitiesCurrent | 7,561,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 15,098,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,563,000 |
| 9 | ResearchAndDevelopmentExpense | 21,684,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,614,000 |
| 13 | remainder_ComprehensiveNetIncome | 17,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,417,000 |
| 1 | Liabilities | 22,659,000 |
| 2 | Expenses | 28,247,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 14,758,000 |
| 5 | NetIncome | -30,861,000 |
| 6 | ComprehensiveNetIncome | -30,852,500 |
| 7 | BaseVar | 45,477,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.0439 |
| 9 | EconomicCapitalRatio | 1.45 |